From the 1Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

2International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts

3Department of Psychiatry, Queen's University School of Medicine, Kingston, Ontario.

Received March 23, 2022; accepted after revision March 30, 2022.

Corresponding Author: Ross J. Baldessarini, M.D., International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts Email: [email protected]

Supported in part by a grant from the Bruce J. Anderson Foundation and by the McLean Private Donors Research Fund (to RJB).